Catalyst Wire Dossier Catalyst Wire Dossier

divalproex sodium delayed-release tablets, 500 mg

divalproex sodium · Mylan Pharmaceuticals Inc
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for divalproex sodium delayed-release tablets, 500 mg, covering 2010-08-18 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions [Phase 1]

See pricing